Joshua Patterson
No más puestos en curso
Fortuna: 5 078 $ al 30/04/2024
Historial de carrera de Joshua Patterson
Antiguos cargos conocidos de Joshua Patterson.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| GAMIDA CELL LTD. | Oficial de Cumplimiento | 01/08/2021 | 26/04/2024 |
| Consejero General | 01/08/2021 | 26/04/2024 | |
| IONIS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/12/2006 | 01/03/2018 |
| Corporate Officer/Principal | 01/12/2006 | 01/03/2018 | |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/10/2000 | 01/09/2006 |
| AKCEA THERAPEUTICS, INC. | Consejero General | 01/03/2018 | - |
| Secretario Corporativo | 01/03/2018 | 11/03/2020 |
Formación de Joshua Patterson.
| Carthage College | Undergraduate Degree |
| Syracuse University | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
| Israel | 2 |
Operativa
| General Counsel | 2 |
| Corporate Officer/Principal | 2 |
| Corporate Secretary | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| GAMIDA CELL LTD. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Joshua Patterson
- Experiencia
